Results for “ ”

Entry Author Date Location
Clinical Trial Lab Intrinsic Imaging Joins Rise of AI in Radiology 10/20/17 Texas
Bio Roundup: Kite’s CAR-T Approved, Obamacare Fix & Lilly mRNA Deal 10/20/17 National
For Key Study, UniQure Allowed to Swap Hemophilia Gene Therapies 10/19/17 Boston
Kite Nabs First Adult CAR-T Approval With Notable Uptick Of Cures 10/18/17 National
Eli Lilly to Pursue mRNA Cancer Vaccines with CureVac Pact 10/18/17 Indiana
Vir Biotech Vies for Global Approach to Tackling Infectious Disease 10/18/17 San Francisco
After Trump Sounds Off, Senate Has Adult Conversation on Drug Prices 10/17/17 National
Gemini Reels In $42M to Target Root Causes of Age-Related Blindness 10/17/17 Boston
Bridge Project Q&A: “Big Idea” Winners on Connecting Cancer Experts 10/16/17 Boston
Vinod Khosla on A.I., Health, and the Future of Working (or Not) 10/16/17 San Francisco
JLABS Takes Stock of Its Experiment in Life Sciences Innovation 10/13/17 San Diego
Healthcare + A.I. at Pfizer on Nov. 2: Here’s the Agenda 10/13/17 Boston
Bio Roundup: Light For Spark, California Drug Law, IPO Queue & More 10/13/17 National
FDA To Advisors: What If One-Time Gene Therapy Needs Extra Doses? 10/10/17 National
KalVista, Merck Partnership on Blindness Drug Sends Shares Skyward 10/10/17 Boston
Q&A: Xconomy Award Winner Rob Perez On How Boston Biotech Can Get Involved With The Community 10/10/17 Boston
Bio Roundup: Nobel Pursuit, Fundraising Fruit, A Rhythmic IPO & More 10/06/17 National
Boston’s Life Science Disruptors: The Photos 10/05/17 Boston
Rhythm Pharma IPO Pops to the Tune of a $120M Upsized Offering 10/05/17 Boston
Strata Oncology, UCSF Partner to Offer $25M in Free Tumor Sequencing 10/05/17 Detroit Ann Arbor
Xconomy Award Winner Lita Nelsen Reflects on a Career in Tech Transfer: Q&A 10/04/17 Boston
Palleon Lands $48M to Develop New Type of Checkpoint Cancer Drug 10/04/17 Boston
Ultragenyx Sweetens Offer, Dimension Tx Agrees to $151M Acquisition 10/03/17 San Francisco
Celebrating Boston Life Sciences: Xconomy Awards Gala Slideshow 10/03/17 Boston
Cullinan Oncology Emerges with $150M to Build Cancer Drug Portfolio 10/03/17 Boston
CRISPR Therapeutics Switches CEOs As It Approaches First Clinical Study 10/02/17 Boston
KSQ Bets on CRISPR-Juiced Drug Discovery With $76M & Ex-Genzyme CEO 10/02/17 Boston
Bio Roundup: Graham-Cassidy, Axovant Fail, SpringWorks Launches & More 09/29/17 National
Deciphera IPO Drums Up $128M for Cancer Drug Studies 09/28/17 Boston
FDA Panel Pans PTC’s Audacious Plan to Force Vote on Duchenne Drug 09/28/17 New York
Page 2 of 129 « previous page · next page »